23Andme Historical Financial Ratios

ME Stock

USD 3.23 0.08 2.54%

23Andme Holding is presently reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 15.84, Book Value Per Share of 0.38 or Invested Capital of 0.0 will help investors to properly organize and evaluate 23Andme Holding financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in 23Andme Holding Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About 23Andme Financial Ratios Analysis

23Andme HoldingFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate 23Andme Holding investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on 23Andme financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across 23Andme Holding history.

23Andme Holding Financial Ratios Chart

At present, 23Andme Holding's PTB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 15.84, whereas Free Cash Flow Yield is forecasted to decline to (0.04).

Price To Sales Ratio Days Sales Outstanding Ev To Sales Inventory Turnover Cash Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing 23Andme Holding stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on 23Andme Holding sales, a figure that is much harder to manipulate than other 23Andme Holding Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most ratios from 23Andme Holding's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into 23Andme Holding current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in 23Andme Holding Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

	2021	2022	2023	2024 (projected)
Payables Turnover	3.66	12.77	10.39	7.42
Days Of Inventory On Hand	28.34	22.67	37.83	20.91

Payables Turnover Days Of Inventory On Hand

23Andme Holding fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.53	0.72	-0.72	0.42	0.76	-0.49	0.53	1.0	0.7	-0.65	-0.36	0.79	0.39	0.31	-0.24	-0.89	-0.23	0.81	0.5	-0.39	-0.41	-0.76	-0.78	-0.3	0.25
Ptb Ratio	0.53		0.81	-0.08	0.28	0.29	0.17	1.0	0.55	0.14	-0.91	-0.48	0.42	0.46	0.15	0.32	-0.57	0.08	0.56	-0.14	0.11	-0.22	-0.26	-0.86	0.04	0.19
Days Sales Outstanding	0.72	0.81		-0.25	0.55	0.76	-0.04	0.81	0.72	0.65	-0.82	-0.24	0.84	0.26	-0.15	-0.23	-0.58	-0.24	0.75	0.15	-0.27	-0.02	-0.65	-0.81	-0.27	0.06
Book Value Per Share	-0.72	-0.08	-0.25		-0.58	-0.52	0.2	-0.08	-0.73	-0.45	0.06	-0.15	-0.37	0.06	-0.39	0.08	0.54	0.65	-0.31	-0.15	0.76	0.56	0.59	0.23	0.7	0.26
Free Cash Flow Yield	0.42	0.28	0.55	-0.58		0.54	0.42	0.28	0.44	0.39	-0.06	0.4	0.48	-0.29	-0.41	-0.05	-0.03	-0.9	0.12	-0.35	-0.87	0.15	-0.35	-0.09	-0.91	-0.74
Operating Cash Flow Per Share	0.76	0.29	0.76	-0.52	0.54		-0.39	0.29	0.76	0.98	-0.45	0.04	0.95	0.02	-0.1	-0.71	-0.57	-0.46	0.75	0.51	-0.58	-0.11	-0.94	-0.53	-0.49	0.01
Capex To Depreciation	-0.49	0.17	-0.04	0.2	0.42	-0.39		0.17	-0.46	-0.54	0.23	0.45	-0.43	-0.42	-0.4	0.57	0.62	-0.39	-0.59	-0.98	-0.17	0.28	0.5	0.36	-0.36	-0.76
Pb Ratio	0.53	1.0	0.81	-0.08	0.28	0.29	0.17		0.55	0.14	-0.91	-0.48	0.42	0.46	0.15	0.32	-0.57	0.08	0.56	-0.14	0.11	-0.22	-0.26	-0.86	0.04	0.19
Ev To Sales	1.0	0.55	0.72	-0.73	0.44	0.76	-0.46	0.55		0.69	-0.66	-0.34	0.78	0.38	0.33	-0.22	-0.89	-0.25	0.81	0.47	-0.41	-0.43	-0.77	-0.79	-0.32	0.23
Free Cash Flow Per Share	0.7	0.14	0.65	-0.45	0.39	0.98	-0.54	0.14	0.69		-0.36	0.03	0.93	0.02	-0.1	-0.83	-0.53	-0.35	0.73	0.66	-0.5	-0.07	-0.94	-0.45	-0.38	0.12
Roic	-0.65	-0.91	-0.82	0.06	-0.06	-0.45	0.23	-0.91	-0.66	-0.36		0.66	-0.58	-0.62	-0.28	-0.03	0.77	-0.28	-0.8	-0.27	-0.23	0.3	0.46	0.98	-0.24	-0.52
Inventory Turnover	-0.36	-0.48	-0.24	-0.15	0.4	0.04	0.45	-0.48	-0.34	0.03	0.66		-0.17	-0.98	-0.45	-0.2	0.58	-0.69	-0.62	-0.39	-0.61	0.26	-0.02	0.68	-0.65	-0.77
Net Income Per Share	0.79	0.42	0.84	-0.37	0.48	0.95	-0.43	0.42	0.78	0.93	-0.58	-0.17		0.21	-0.19	-0.65	-0.59	-0.28	0.83	0.55	-0.41	0.05	-0.83	-0.65	-0.31	0.15
Days Of Inventory On Hand	0.39	0.46	0.26	0.06	-0.29	0.02	-0.42	0.46	0.38	0.02	-0.62	-0.98	0.21		0.46	0.17	-0.57	0.56	0.66	0.37	0.48	-0.29	-0.03	-0.65	0.52	0.67
Payables Turnover	0.31	0.15	-0.15	-0.39	-0.41	-0.1	-0.4	0.15	0.33	-0.1	-0.28	-0.45	-0.19	0.46		0.28	-0.63	0.33	0.28	0.27	0.24	-0.94	-0.19	-0.36	0.28	0.5
Capex To Revenue	-0.24	0.32	-0.23	0.08	-0.05	-0.71	0.57	0.32	-0.22	-0.83	-0.03	-0.2	-0.65	0.17	0.28		0.12	0.17	-0.42	-0.71	0.29	-0.19	0.68	0.02	0.16	-0.15
Cash Per Share	-0.89	-0.57	-0.58	0.54	-0.03	-0.57	0.62	-0.57	-0.89	-0.53	0.77	0.58	-0.59	-0.57	-0.63	0.12		-0.14	-0.84	-0.59	0.02	0.65	0.69	0.88	-0.07	-0.57
Pocfratio	-0.23	0.08	-0.24	0.65	-0.9	-0.46	-0.39	0.08	-0.25	-0.35	-0.28	-0.69	-0.28	0.56	0.33	0.17	-0.14		0.11	0.34	0.97	-0.05	0.35	-0.23	1.0	0.86
Interest Coverage	0.81	0.56	0.75	-0.31	0.12	0.75	-0.59	0.56	0.81	0.73	-0.8	-0.62	0.83	0.66	0.28	-0.42	-0.84	0.11		0.65	-0.04	-0.33	-0.75	-0.87	0.06	0.53
Capex To Operating Cash Flow	0.5	-0.14	0.15	-0.15	-0.35	0.51	-0.98	-0.14	0.47	0.66	-0.27	-0.39	0.55	0.37	0.27	-0.71	-0.59	0.34	0.65		0.13	-0.18	-0.59	-0.38	0.31	0.72
Pfcf Ratio	-0.39	0.11	-0.27	0.76	-0.87	-0.58	-0.17	0.11	-0.41	-0.5	-0.23	-0.61	-0.41	0.48	0.24	0.29	0.02	0.97	-0.04	0.13		0.03	0.49	-0.14	0.98	0.72
Days Payables Outstanding	-0.41	-0.22	-0.02	0.56	0.15	-0.11	0.28	-0.22	-0.43	-0.07	0.3	0.26	0.05	-0.29	-0.94	-0.19	0.65	-0.05	-0.33	-0.18	0.03		0.39	0.39	0.0	-0.29
Income Quality	-0.76	-0.26	-0.65	0.59	-0.35	-0.94	0.5	-0.26	-0.77	-0.94	0.46	-0.02	-0.83	-0.03	-0.19	0.68	0.69	0.35	-0.75	-0.59	0.49	0.39		0.55	0.39	-0.15
Roe	-0.78	-0.86	-0.81	0.23	-0.09	-0.53	0.36	-0.86	-0.79	-0.45	0.98	0.68	-0.65	-0.65	-0.36	0.02	0.88	-0.23	-0.87	-0.38	-0.14	0.39	0.55		-0.17	-0.54
Ev To Operating Cash Flow	-0.3	0.04	-0.27	0.7	-0.91	-0.49	-0.36	0.04	-0.32	-0.38	-0.24	-0.65	-0.31	0.52	0.28	0.16	-0.07	1.0	0.06	0.31	0.98	0.0	0.39	-0.17		0.82
Pe Ratio	0.25	0.19	0.06	0.26	-0.74	0.01	-0.76	0.19	0.23	0.12	-0.52	-0.77	0.15	0.67	0.5	-0.15	-0.57	0.86	0.53	0.72	0.72	-0.29	-0.15	-0.54	0.82

Click cells to compare fundamentals

23Andme Holding Account Relationship Matchups

23Andme Holding fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	13.04	16.95	6.15	3.44	22.84	23.98
Ptb Ratio	29.68	(6.94)	1.83	1.44	26.61	27.94
Days Sales Outstanding	7.64	3.71	4.54	2.31	15.08	15.84
Book Value Per Share	6.6	(29.31)	41.95	31.62	0.4	0.38
Free Cash Flow Yield	(0.0651)	(0.0197)	(0.11)	(0.17)	(0.0347)	(0.0364)
Operating Cash Flow Per Share	(9.14)	(3.65)	(7.64)	(7.33)	(0.35)	(0.36)
Stock Based Compensation To Revenue	0.15	0.36	0.21	0.39	0.55	0.57
Capex To Depreciation	3.16	0.36	0.53	0.31	0.0383	0.0364
Pb Ratio	29.68	(6.94)	1.83	1.44	26.61	27.94
Ev To Sales	12.65	16.17	4.43	2.43	22.2	23.31
Free Cash Flow Per Share	(12.76)	(4.02)	(8.28)	(7.83)	(0.37)	(0.38)
Roic	(1.1)	0.31	(0.25)	(0.4)	(1.63)	(1.55)
Inventory Turnover	11.9	20.34	12.88	16.1	9.65	16.45
Net Income Per Share	(14.24)	(9.02)	(9.96)	(13.81)	(1.4)	(1.47)
Days Of Inventory On Hand	30.68	17.94	28.34	22.67	37.83	20.91
Payables Turnover	12.84	10.34	3.66	12.77	10.39	7.42
Sales General And Administrative To Revenue	0.19	0.41	0.36	0.39	0.59	0.62
Research And Ddevelopement To Revenue	0.59	0.66	0.7	0.74	0.93	0.53
Capex To Revenue	0.24	0.0302	0.0514	0.0377	0.00514	0.004883
Cash Per Share	10.3	13.9	25.34	17.14	0.46	0.43
Pocfratio	(21.44)	(55.67)	(10.02)	(6.22)	(30.53)	(32.06)
Capex To Operating Cash Flow	(0.4)	(0.0993)	(0.0838)	(0.0684)	(0.006871)	(0.007214)
Pfcf Ratio	(15.36)	(50.64)	(9.25)	(5.83)	(28.84)	(30.28)
Days Payables Outstanding	28.42	35.29	99.64	28.59	35.12	53.48
Roe	(2.16)	0.31	(0.24)	(0.44)	(3.54)	(3.36)
Ev To Operating Cash Flow	(20.8)	(53.13)	(7.22)	(4.4)	(29.67)	(31.15)
Pe Ratio	(13.77)	(22.54)	(7.69)	(3.3)	(7.52)	(7.9)
Return On Tangible Assets	(0.72)	(0.41)	(0.3)	(0.59)	(1.95)	(1.86)
Ev To Free Cash Flow	(14.9)	(48.33)	(6.67)	(4.12)	(28.02)	(29.43)
Intangibles To Total Assets	0.0134	0.0152	0.38	0.44	0.14	0.13
Net Debt To E B I T D A	0.62	1.14	2.05	1.03	0.48	0.46
Current Ratio	1.76	2.58	3.93	2.84	1.97	2.11
Tangible Book Value Per Share	6.34	(29.65)	22.01	13.33	0.28	0.27
Receivables Turnover	47.79	98.32	80.44	157.88	24.2	22.99
Graham Number	45.99	77.14	96.98	99.11	3.53	3.36
Shareholders Equity Per Share	6.6	(29.31)	41.95	31.62	0.4	0.38
Capex Per Share	3.62	0.36	0.64	0.5	0.002372	0.002253

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

How To Invest In 23Andme

Details

Is 23Andme Stock a good investment?

Details

What is 23Andme Holding's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(122.52)

Revenue Per Share

8.224

Quarterly Revenue Growth

(0.34)

Return On Assets

(0.26)

Return On Equity

(1.54)

The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

23Andme Historical Financial Ratios

About 23Andme Financial Ratios Analysis

23Andme Holding Financial Ratios Chart

Price To Sales Ratio

Ev To Sales

Inventory Turnover

23Andme Holding fundamentals Correlations

23Andme Holding Account Relationship Matchups

High Positive Relationship

High Negative Relationship

23Andme Holding fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Roe	+ 0.98	Roic
Ev To Operating Cash Flow	+ 0.98	Pfcf Ratio

Days Of Inventory On Hand	- 0.98	Inventory Turnover
Capex To Operating Cash Flow	- 0.98	Capex To Depreciation
Days Payables Outstanding	- 0.94	Payables Turnover
Income Quality	- 0.94	Free Cash Flow Per Share
Income Quality	- 0.94	Operating Cash Flow Per Share
Roic	- 0.91	Pb Ratio